Extremely High Cost Drugs

July 29th, 2017
bio, ideas
Let's say a company discovers a new drug that's far more effective than the current standard of care. [1] They get it through clinical trials, it still looks amazing, then they start selling it. But they set the price incredibly high.

My understanding is that insurance companies in the US are not allowed to refuse to cover a drug on the basis of cost, and they're not allowed to have limits on what they'll pay for someone's care. So what happens? Why aren't new drugs much much more expensive than they currently are?

Update 2017-08-01: From the comments it sounds like it's coinsurance (percentage co-pays) on high cost drugs that keeps this in check.


[1] If it's only a little bit better the insurance company could argue "sure it looks good in your N=500 tests, but we don't think this effect will hold up" or something. But if it's plainly much better then they wouldn't be successful with this I think?

Comment via: google plus, facebook, substack

Recent posts on blogs I like:

Retrospective on life tracking and effectiveness systems

I’ve been doing life tracking for around 10 years, and this post is looking back at some things I learned from the data (since my previous retrospective in 2017). I also review various productivity / effectiveness systems I have tried and which ones have …

via Victoria Krakovna July 4, 2025

Linkpost for June

Effective altruism, policy, social justice, reality's surprising amount of detail, short stories

via Thing of Things July 2, 2025

Elixir's Last Dance

On May 18th, the contra dance band Elixir had their last gig ever. The dance was packed: there were three hundred people. It was the only dance BIDA has ever done where they sold tickets. People flew from across the country just to hear Elixir play one la…

via Lily Wise's Blog Posts June 5, 2025

more     (via openring)